To further confirm the cGAS-STING activation-induced DC maturation, the highly potent and selective inhibitors (RU.521, C-178, or C-176) of the cGAS-STING pathway were separately added when incubating BMDCs with MTHMS + L treated cancer cells48–50. The gene discussed is CGAS; the disease is cancer.